SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Sequent Scientific - Quaterly Results

08 Aug 2025 Evaluate
The sales declined to Rs. 410.70 millions for the June 2025 quarter as compared to Rs. 576.70 millions during the corresponding quarter last year.The Company's Net profit for the June 2025 quarter have declined marginally to Rs. 33.70  millions as against Rs. 45.00 millions reported during the corresponding quarter ended.Operating Profit saw a handsome growth to 94.40 millions from 88.60 millions in the quarter ended June 2025.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202506 202406 % Var 202506 202406 % Var 202503 202403 % Var
Sales 410.70 576.70 -28.78 410.70 576.70 -28.78 1782.60 1685.20 5.78
Other Income 114.80 108.40 5.90 114.80 108.40 5.90 509.40 459.80 10.79
PBIDT 94.40 88.60 6.55 94.40 88.60 6.55 395.60 193.20 104.76
Interest 10.80 8.10 33.33 10.80 8.10 33.33 39.60 43.60 -9.17
PBDT 71.10 80.50 -11.68 71.10 80.50 -11.68 307.20 87.10 252.70
Depreciation 23.30 20.00 16.50 23.30 20.00 16.50 86.70 89.40 -3.02
PBT 47.80 60.50 -20.99 47.80 60.50 -20.99 220.50 -2.30 -9686.96
TAX 14.10 15.50 -9.03 14.10 15.50 -9.03 62.50 -8.60 -826.74
Deferred Tax 5.70 5.80 -1.72 5.70 5.80 -1.72 23.70 -13.20 -279.55
PAT 33.70 45.00 -25.11 33.70 45.00 -25.11 158.00 6.30 2407.94
Equity 500.70 499.00 0.34 500.70 499.00 0.34 500.60 498.90 0.34
PBIDTM(%) 22.99 15.36 49.61 22.99 15.36 49.61 22.19 11.46 93.57

Viyash Scientific Share Price

208.35 1.05 (0.51%)
21-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1665.25
Dr. Reddys Lab 1220.75
Cipla 1232.90
Zydus Lifesciences 928.85
Lupin 2311.75
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×